Member Profile mfglola | Latest Posts

INmune Bio's TNF inhibitor targetin

07/04/2025 8:49:15 AM

(1)

AstraZeneca contemplating a $15B li

07/03/2025 6:57:19 PM

(10)

Dr. Weinberg had an oral presentati

07/03/2025 1:40:53 PM

(5)

DSP107 + atezolizumab in 3L MSS crc

07/01/2025 1:45:39 PM

In addition to its potential as a �

07/01/2025 12:00:46 PM

I'm thinking, even if we doubled it

07/01/2025 12:16:58 AM

"Pharma companies rush in to buy wh

06/05/2025 10:37:00 AM

(11)

prostate cancer is now in stage pre

06/04/2025 10:49:28 PM

(5)

Merck won't partner with Gilead in

06/02/2025 7:49:19 PM

Overall Survival and Quality-of-Lif

06/02/2025 3:56:59 PM

(8)

Sorry, I don't know how to post an

06/02/2025 3:43:18 PM

(13)

Came across this on X. Let's hope s

06/02/2025 3:31:44 PM

(1)

Yes, the FDA has accepted PD-L1 as

05/19/2025 12:21:27 PM

(9)

I don't know if an ICI will ever b

05/17/2025 6:31:38 PM

"Upregulation of PD-L1 was seen in

05/16/2025 11:51:40 AM

I am completely baffled as to how m

05/15/2025 9:09:22 AM

I'm more focused on Roche, which ha

05/13/2025 11:45:22 PM

the "50% survival level"...DIDN'T E

05/02/2025 7:03:01 AM

What is Gilead's hope/intention by

04/24/2025 9:15:10 AM

If not, are there other types of br

04/10/2025 7:36:14 PM

The trial you linked must have used

03/26/2025 9:46:30 AM

The hidden scars of ulcerative coli

03/13/2025 10:08:08 AM

(9)

I see Dr. P will be on Steve Kirsch

02/27/2025 3:53:01 PM

A discovery at Duke-NUS Medical Sch

02/22/2025 5:54:11 PM

(14)

maraviroc is now a generic drug , n

02/12/2025 11:01:01 PM

I haven't ran across any studies lo

01/27/2025 8:59:51 PM

(8)

Agenus' botensilimab/balstilimab co

01/27/2025 8:32:33 AM

Mediar Therapeutics Enters into Glo

01/10/2025 8:39:05 AM

Calico’s fosigotifator was tested

01/08/2025 6:16:03 PM

Maybe I missed it, but I don't reme

12/15/2024 1:39:02 PM

I'm sure he's very aware of the sto

12/12/2024 7:41:59 PM

And playing six degrees of leronlim

12/09/2024 8:45:57 AM

(8)

Maybe it is the Gates Foundation th

12/06/2024 8:09:36 PM

(14)

The dosing schedule should be and t

11/22/2024 3:39:58 PM

I think someone (Ohm?) should make

11/14/2024 11:26:32 PM

Upregulation of CCL4 after treatmen

11/13/2024 2:34:34 PM

Surrogate reads like anecdotal is b

11/05/2024 6:59:00 AM

HOW are they able to showcase "slow

10/31/2024 9:07:29 PM

What is a bit strange is that they

10/31/2024 11:20:29 AM

(1)

Familial ALS? I'm so sorry. That mu

10/30/2024 8:40:24 AM

Coya yesterday reported their low d

10/30/2024 7:01:05 AM

I would expect academic institution

10/29/2024 8:36:20 PM

Ohm - do you discount the possibili

10/29/2024 10:54:47 AM

At a townhall in Lancaster PA, Elon

10/28/2024 8:19:27 AM

(13)

A fascinating conversation on ccr5

10/19/2024 6:16:10 PM

Findings may guide future Parkinson

10/11/2024 12:33:51 PM

(5)

Since it is an open label study, it

10/06/2024 2:11:04 PM

Interesting connection between two

09/29/2024 8:34:15 AM

Pegozafermin received BTD for MASH

09/26/2024 6:05:26 PM

The publication shows that 76% of p

09/24/2024 11:10:02 PM